Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF711 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
mRNA | MCHR2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | VPS37A | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | S100A10 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
mRNA | PHLDA2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | TJAP1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | SELM | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | ELP4 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | UBL3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | PREPL | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |